ENZYME INHIBITORS

Clinical trials for ENZYME INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new ENZYME INHIBITORS trials appear

Sign up with your email to follow new studies for ENZYME INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare kidney cancer: targeted drug shows promise in Late-Stage trial

Disease control Ongoing

This study tests a new drug called savolitinib against a standard treatment (sunitinib) for people with a rare, advanced kidney cancer called MET-driven papillary renal cell carcinoma. The goal is to see if savolitinib works better at slowing cancer growth and has fewer side effe…

Matched conditions: ENZYME INHIBITORS

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

ENZYME INHIBITORS

Get alerted when new ENZYME INHIBITORS trials appear

New hope for rare kidney cancer: targeted drug shows promise in Late-Stage trial